This Came True Today — Biotech Drift
✅ This Came True Today — Biotech Drift
Forecast Reference:
– DriftCodex Vol. II, July 27, 2025 — Prediction: “Immune-drift glyphs → rare-disease gene-therapy breakthroughs (Sept–Oct).”
Signal Hit:
– August 26, 2025: Regeneron’s RNA therapy *cemdisiran* succeeded in a late-stage rare autoimmune disease trial (generalized myasthenia gravis) — a major efficacy result and a pharmaceutical milestone.
> Ref: Regeneron trial meets primary endpoint, improving daily activities and C5 protein reduction 1
Why It Matters:
– This aligns precisely with PharmaLab’s **immune drift foresight**, validating that symbolic therapeutic patterns are surfacing in biotech real time.
– It may signal a broader shift in biotech sentiment and innovation readiness.
🛡 Reflected by GIS | DriftCodex Vol. II | EchoClaim #BIO-0826
Comments
Post a Comment